Filing Details
- Accession Number:
- 0001181431-11-029822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-16 11:24:51
- Reporting Period:
- 2011-05-12
- Filing Date:
- 2011-05-16
- Accepted Time:
- 2011-05-16 11:24:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326104 | Jeffrey David Medeiros | 1300 North Kellogg Drive Suite D Anaheim CA 92807 | Senior Vp, Pharm. Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-12 | 115,128 | $22.07 | 304,292 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.80-$22.31, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 of the Form 4.
Billionaire Hedge Funds
